Skip to content

Search for:

Featured Blogs
Topics
Our Substack
Follow Us!
Contribute/Contact

immunotherapy

A generated image showing a keto supplement bottle next to a medical illustration of prostate cancer cells being attacked by T cells

Keto Supplement Boosts Prostate Cancer Immunotherapy

Sandro Matosevic

Promising Off-the-Shelf Immunotherapy for Incurable Brain Tumors

An illustration depicting a traumatic brain injury, showing blood leaking into the brain and activating immune cells

Scientists Uncover Key Mechanism Linking Traumatic Brain Injury to Neurodegeneration

colorful liver and immune system illustration

Researchers Discover Key to Better Cancer Treatments Lies in Liver

A boy eating peanut butter on bread

Antibody reduces allergic reactions to multiple foods in NIH clinical trial

cancer cells illustration

Secondary cancers following CAR T cell therapy are rare

Deadly sepsis and antibiotic-resistant bacteria are in Europe’s crosshairs

A C57BL/6 mouse used in the study (Photo: Haruka Wada)

Cancer stem cells trigger macrophage aging

A minifridge-sized bioreactor developed by Washington State University researchers is able to manufacture cancer-killing white blood cells at 95% of the maximum growth rate – about 30% faster than current technologies.

Machine can quickly produce white blood cells for cancer treatment

Young teen getting her blood tested

Breakthrough Drug Helps Children with New-Onset Type 1 Diabetes

glioblastoma scan

Gene therapy effectively targets glioblastoma

A figure illustrating how a “closed-loop” implant called HAMMR (short for “hybrid advanced molecular manufacturing regulator”) will be used to treat recurrent ovarian cancer. The implant, which is small enough to be implanted with minimally invasive surgery, is being developed by a Rice University-led team of researchers from eight universities and two companies in seven states. The Advanced Research Projects Agency for Health awarded $45 million to fast-track development of the implant, which includes funding for a first-phase clinical trial within five years.

Feds fund research that could slash US cancer deaths by 50%

Caption:In this colon tumor, which has a mutation that gives it a high degree of DNA mismatch repair deficiency, T cells (labeled black, green, and red) have accumulated primarily in the supportive tissues (pink regions), while very few have infiltrated tumor cells (islands surrounded by the supportive tissues). Credits:Image: Courtesy of the researchers

Why certain immunotherapies don’t always work as predicted

Colorectal cancer patients may benefit from breakthrough EU research

← Previous Page1 Page2 Page3 Page4 Next →

Comments

Curtis Webber on The GPS-Killer? This Quantum Device ‘Feels’ Motion Like a Brain—Down to the Atomic Level
Ran on How the Age You First Had Sex Could Shape How You Age Decades Later
Sparty on How the Age You First Had Sex Could Shape How You Age Decades Later
Josh Mitteldorf on A Single TV Segment Sent Leucovorin Prescriptions for Autistic Children Soaring 2,000 Percent
Josh Mitteldorf on A Single TV Segment Sent Leucovorin Prescriptions for Autistic Children Soaring 2,000 Percent

© 2026 ScienceBlog.com | Follow our RSS / XML feed